Description

Therapeutic effects of MR pathway blockade applied after Spike protein pre-treatment simulate intervention during active infection, showing that MR antagonists can reduce established endothelial inflammation.

Figure 10

Chart

Source Paper

Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein.

Biomedicines (2021)

PMID: 34204890

DOI: 10.3390/biomedicines9060639

Cite This Figure

![Figure 10: Therapeutic effects of MR pathway blockade applied after Spike protein pre-treatment simulate intervention during active infection, showing that MR antagonists can reduce established endothelial inflammation.]()

> Source: Eva Jover et al. "Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endoth." *Biomedicines*, 2021. PMID: [34204890](https://pubmed.ncbi.nlm.nih.gov/34204890/)

<figure>
  <img src="" alt="Therapeutic effects of MR pathway blockade applied after Spike protein pre-treatment simulate intervention during active infection, showing that MR antagonists can reduce established endothelial inflammation." />
  <figcaption>Figure 10. Therapeutic effects of MR pathway blockade applied after Spike protein pre-treatment simulate intervention during active infection, showing that MR antagonists can reduce established endothelial inflammation.<br>  Source: Eva Jover et al. "Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endoth." <em>Biomedicines</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34204890/">34204890</a></figcaption>
</figure>

Related Evidence

Iron for Pediatric Immune Support

Grade C · 5 studies